Increased mIndy levels are associated with obesity and insulin insensitivity in patients with non-alcoholic fatty liver disease (NAFLD) (von Loeffelholz et al., 2017). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.